$AXSM insider trading
Over the last 12 months, Axsome Therapeutics insiders reported 1 buy totaling $200K and 26 sales totaling $152.6M across SEC Form 4 filings. 96% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $200K 1 event
- Sold · 12m
- $152.6M 26 events
- Events · 12m
- 27 Form 4 filings, grouped
- Insiders · 12m
- 8 distinct reporters
- 10b5-1 share
- 96% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,664 | $212.19 | $10.5M | -87.3% | plan · 2 tranches |
| Jul 1, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,666 | $240.25 | $11.9M | -87.3% | plan |
| Jun 11, 2026 | JEFFS ROGERD | ▼ Sale | 572 | $247.65 | $142K | -1% | plan · 2 tranches |
| Jun 10, 2026 | Mahony SusanD | ▼ Sale | 600 | $241.7 | $145K | -42% | plan · 2 tranches |
| Jun 10, 2026 | Coleman MarkD | ▼ Sale | 643 | $249 | $160K | -2.1% | plan |
| Jun 9, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,670 | $241.01 | $12.0M | -87.3% | plan |
| Jun 9, 2026 | Pizzie NickChief Financial Officer · O | ▼ Sale | 33,000 | $240.09 | $7.9M | -43.5% | plan |
| Jun 2, 2026 | Coleman MarkD | ▼ Sale | 5,537 | $223.39 | $1.2M | -15.8% | plan |
| Jun 1, 2026 | Coleman MarkD | ▼ Sale | 6,000 | $230.3 | $1.4M | -14.6% | plan |
| May 29, 2026 | Coleman MarkD | ▼ Sale | 6,000 | $233.46 | $1.4M | -12.7% | plan |
| May 5, 2026 | Jacobson Mark L.Chief Operating Officer · O | ▼ Sale | 4,750 | $227.95 | $1.1M | -100% | plan · 2 tranches |
| Apr 22, 2026 | Maizel AriChief Commercial Officer · O | ▼ Sale | 7,500 | $182.42 | $1.4M | -100% | plan |
| Feb 26, 2026 | Coleman MarkD | ▼ Sale | 25,000 | $161.11 | $4.0M | -34.7% | plan |
| Feb 26, 2026 | Jacobson Mark L.Chief Operating Officer · O | ▼ Sale | 35,378 | $161.88 | $5.7M | -100% | plan |
| Feb 2, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 32,410 | $185.6 | $6.0M | -81.8% | plan |
| Jan 22, 2026 | Pizzie NickChief Financial Officer · O | ▼ Sale | 12,000 | $187.92 | $2.3M | -22% | plan |
| Jan 21, 2026 | Maizel AriChief Commercial Officer · O | ▼ Sale | 7,500 | $184.44 | $1.4M | -100% | plan |
| Jan 7, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 139,414 | $171.3 | $23.9M | -95.1% | plan · 3 tranches |
| Dec 31, 2025 | Saad Mark ED | ▼ Sale | 37,577 | $165.18 | $6.2M | -79% | plan · 2 tranches |
| Dec 4, 2025 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 79,973 | $145.66 | $11.6M | -91.7% | plan · 3 tranches |
| Nov 5, 2025 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 163,939 | $133.07 | $21.8M | -95.8% | plan · 3 tranches |
| Oct 8, 2025 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 45,384 | $119.38 | $5.4M | -86.3% | plan · 3 tranches |
| Sep 22, 2025 | Jacobson Mark L.Chief Operating Officer · O | ▼ Sale | 10,000 | $115.96 | $1.2M | -100% | plan |
| Sep 16, 2025 | Jacobson Mark L.Chief Operating Officer · O | ▼ Sale | 45,783 | $114.48 | $5.2M | -100% | plan · 2 tranches |
| Sep 16, 2025 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 62,880 | $117.08 | $7.4M | -89.7% | plan · 3 tranches |
| Sep 8, 2025 | Coleman MarkD | ▲ Buy | 1,575 | $127.28 | $200K | +3.4% | 3 tranches |
| Sep 5, 2025 | Saad Mark ED | ▼ Sale | 9,127 | $125.07 | $1.1M | -47.7% | plan |
| Sep 2, 2025 | JEFFS ROGERD | ▼ Sale | 13,464 | $123.68 | $1.7M | -19% | plan |
| Aug 29, 2025 | JEFFS ROGERD | ▼ Sale | 60,000 | $121.72 | $7.3M | -45.8% | plan · 3 tranches |
| Aug 26, 2025 | JEFFS ROGERD | ▼ Sale | 36,694 | $120.05 | $4.4M | -21.9% | plan · 2 tranches |
Every $AXSM filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Axsome Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AXSM feed.